Patent ID: 11872250
Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 0:
1. A method for inducing an immune response in a patient in need thereof comprising administering to said patient an effective amount of:
(a) a population of isolated trained mesenchymal stem cells;
(b) isolated IFNγ; and
(c) an effective amount of at least one cytokine for inducing an immune response, the at least one cytokine selected from the group consisting of interleukin-1 alpha (IL-1 α), interleukin-1 beta (IL-1 β), Type 1 interferon alpha (IFN-I α), Type 1 interferon beta (IFN-I β), tumor necrosis factor alpha (TNF α), transforming growth factor beta (TGF β), and fibroblast growth factor (FGF).